Theravance Biopharma (TBPH) Raw Materials (2013 - 2018)

Theravance Biopharma (TBPH) has reported Raw Materials for 6 consecutive years, with $10.8 million the latest figure, recorded in Q3 2018.

• In Q3 2018, Raw Materials rose 8.41% year-over-year to $10.8 million; the TTM figure through Sep 2018 stood at $10.8 million (up 8.41% YoY), while the FY2017 annual figure was $11.7 million, up 93.32% from the prior year.
• Raw Materials climbed to $10.8 million in Q3 2018 per TBPH's latest filing, from $10.6 million in the prior quarter.
• Across five years, Raw Materials topped out at $11.7 million in Q4 2017 and bottomed at $4.0 million in Q1 2014.
• Historically, Raw Materials has averaged $7.6 million across 5 years, with a median of $6.9 million in 2015.
• Annual changes were most pronounced in 2016 — Raw Materials decreased 21.94% — and 2017, when it jumped 93.32%.
• Theravance Biopharma's Raw Materials stood at $6.8 million in 2014, then climbed by 0.57% to $6.9 million in 2015, then retreated by 11.68% to $6.1 million in 2016, then surged by 93.32% to $11.7 million in 2017, then declined by 8.05% to $10.8 million in 2018.
• Business Quant data shows TBPH's Raw Materials at $10.8 million in Q3 2018, $10.6 million in Q2 2018, and $10.6 million in Q1 2018.